Exercise-Induced Central Fatigue: Biomarkers, and Non-Medicinal Interventions DOI Creative Commons
Ying Yang, Zhi Wei Feng,

Yu-hang Luo

и другие.

Aging and Disease, Год журнала: 2024, Номер unknown, С. 0 - 0

Опубликована: Янв. 1, 2024

Fatigue, commonly experienced in daily life, is a feeling of extreme tiredness, shortage or lack energy, exhaustion, and difficulty performing voluntary tasks. Central fatigue, defined as progressive failure to voluntarily activate the muscle, typically linked moderate- light-intensity exercise. However, some instances, high-intensity exercise can also trigger onset central fatigue. Exercise-induced fatigue often precedes decline physical performance well-trained athletes. This leads reduction nerve impulses, decreased neuronal excitability, an imbalance brain homeostasis, all which adversely impact athlete's longevity their sports career. Therefore, implementing strategies delay exercise-induced vital for enhancing athletic safeguarding athletes from debilitating effects In this review, we discuss structural basis, measurement methods, biomarkers Furthermore, propose non-pharmacological interventions mitigate its effects, potentially foster improvements athletes' performances healthful sustainable manner.

Язык: Английский

Mitochondrial-Oriented Injectable Hydrogel Microspheres Maintain Homeostasis of Chondrocyte Metabolism to Promote Subcellular Therapy in Osteoarthritis DOI Creative Commons
Li Chen,

Jianye Yang,

Zhengwei Cai

и другие.

Research, Год журнала: 2024, Номер 7

Опубликована: Янв. 1, 2024

Subcellular mitochondria serve as sensors for energy metabolism and redox balance, the dynamic regulation of functional dysfunctional plays a crucial role in determining cells' fate. Selective removal at subcellular level can provide chondrocytes with to prevent degeneration, thereby treating osteoarthritis. Herein, achieve an ideal therapy, cartilage affinity peptide (WYRGRL)-decorated liposomes loaded mitophagy activator (urolithin A) were integrated into hyaluronic acid methacrylate hydrogel microspheres through microfluidic technology, named HM@WY-Lip/UA, that could efficiently target selectively remove mitochondria. As result, this system demonstrated advantage function restoration, reactive oxygen species scavenging, cell survival rescue, chondrocyte homeostasis maintenance increasing mitophagy. In rat post-traumatic osteoarthritis model, intra-articular injection HM@WY-Lip/UA ameliorated matrix degradation, osteophyte formation, subchondral bone sclerosis 8 weeks. Overall, study indicated provided protective effect on degeneration efficacious clinically relevant manner, mitochondrial-oriented strategy has great potential therapy

Язык: Английский

Процитировано

22

Therapeutic role of hucMSC-sEV-enriched miR-13896 in cisplatin-induced acute kidney injury through M2 macrophage polarization DOI Creative Commons
Can Jin, Peipei Wu, Wei Wu

и другие.

Cell Biology and Toxicology, Год журнала: 2025, Номер 41(1)

Опубликована: Фев. 24, 2025

Human umbilical cord mesenchymal stem cell-derived small extracellular vesicles (hucMSC-sEV) have recently garnered attention as a potential therapeutic approach for kidney diseases with anti-inflammatory effects. Infiltrated macrophages play an important role in facilitating tissue regeneration. However, the intricate regulatory effects of hucMSC-sEV on during cisplatin-induced acute injury (AKI) remain unknown. In this study, we uncovered that exhibited potent anti-inflammation and effectively inhibited polarization M1 phenotype macrophages. Mechanically, miRNA sequencing analysis qRT-PCR indicated novel miRNA, named miR-13896, was enriched hucMSC-sEV. When transfected miR-13896 mimic, displayed M2 elevated levels Arg1 IL-10, while inhibitor promoted phenotype. Furthermore, firstly established repressed Tradd expression by targeting its 3' untranslated region subsequently NF-κB signaling pathway Additionally, to improve effects, were engineered through electroporation, which resulted promoting macrophages, inhibiting inflammatory factors, enhancing repair. Conclusively, our findings provide insights into mechanisms underlying AKI, also highlighting electroporation promising strategy treating AKI.

Язык: Английский

Процитировано

3

Harnessing Nanomedicine for Cartilage Repair: Design Considerations and Recent Advances in Biomaterials DOI
Huiqun Zhou, Zhen Zhang, Yulei Mu

и другие.

ACS Nano, Год журнала: 2024, Номер 18(16), С. 10667 - 10687

Опубликована: Апрель 9, 2024

Cartilage injuries are escalating worldwide, particularly in aging society. Given its limited self-healing ability, the repair and regeneration of damaged articular cartilage remain formidable challenges. To address this issue, nanomaterials leveraged to achieve desirable outcomes by enhancing mechanical properties, optimizing drug loading bioavailability, enabling site-specific targeted delivery, orchestrating cell activities at nanoscale. This review presents a comprehensive survey recent research nanomedicine for repair, with primary focus on biomaterial design considerations advances. The commences an introductory overview intricate microenvironment further delves into key parameters crucial treating damage, including microstructure, surface charge, active targeting. focal point lies advances nano delivery systems nanotechnology-enabled 3D matrices repair. We discuss compositions properties these elucidate how materials impact cartilage. underscores pivotal role nanotechnology improving efficacy biomaterials utilized treatment damage.

Язык: Английский

Процитировано

13

Intra‐Articular Injection of Nanomaterials for the Treatment of Osteoarthritis: From Lubrication Function Restoration to Cell and Gene Therapy DOI

Yinuo Yang,

Hongyu Zhang

Advanced Functional Materials, Год журнала: 2024, Номер 34(30)

Опубликована: Май 1, 2024

Abstract Osteoarthritis (OA), a prevalent joint disease affecting many people globally, presents significant challenge in current treatments, which often only manage symptoms without halting progression. This review illuminates novel approaches OA therapy, focusing mainly on intra‐articular injection of nanomaterials. The innovative materials, designed to either mimic or augment natural lubrication, show promise restoring biomechanics and alleviating pain. delves into an array biomimetic lubricants, including polymer brush, nanocomposite hydrogel, nanoparticles, underscoring their roles anti‐inflammation, targeting, cartilage repair, drug delivery. Furthermore, the potential mesenchymal stem cells differentiate chondrocytes, coupled with delivery these exosomes via nanomaterials, has promoted cell therapy avenues for OA. also highlights function non‐coding RNAs such as miRNA, siRNA, circRNA, lncRNA, antisense oligonucleotides impeding progression, nanomaterials facilitating delivery, thus advanced therapeutic possibilities immune evasion bone proliferation. Overall, this encapsulates evolution treatment from material cell, ultimately gene forecasting future where evolve toward integrated, personalized diagnostics therapeutics

Язык: Английский

Процитировано

12

Extracellular derivatives for bone metabolism DOI Creative Commons
Yan Wu,

Peiran Song,

Miaomiao Wang

и другие.

Journal of Advanced Research, Год журнала: 2024, Номер 66, С. 329 - 347

Опубликована: Янв. 11, 2024

Bone metabolism can maintain the normal homeostasis and function of bone tissue. Once balance is broken, it will cause osteoporosis, osteoarthritis, defects, tumors, or other diseases. However, such orthopedic diseases still have many limitations in clinical treatment, as drug restrictions, tolerance, side effects, implant rejection. review: In complex therapy regeneration, extracellular derivatives become a promising research focus to solve problems metabolic These derivatives, which include components matrix, growth factors, vesicles, significant therapeutic potential. It has advantages good biocompatibility, low immune response, dynamic demand for The purpose this review provide comprehensive perspective on elucidate intrinsic properties versatility derivatives. Further discussion them innovative advanced materials improving effectiveness regeneration processes. Key scientific concepts review, we first listed types functions three Then, discussed effects different cell sources metabolism. Subsequently, collected applications treatment summarized challenges applications. Finally, prospected novel We hope that understanding new solutions

Язык: Английский

Процитировано

11

Engineered MSC‐sEVs as a Versatile Nanoplatform for Enhanced Osteoarthritis Treatment via Targeted Elimination of Senescent Chondrocytes and Maintenance of Cartilage Matrix Metabolic Homeostasis DOI Creative Commons
Kai Feng, Jiashuo Liu,

Liangzhi Gong

и другие.

Advanced Science, Год журнала: 2025, Номер unknown

Опубликована: Янв. 4, 2025

Abstract Chondrocyte senescence is an important pathogenic factor causing osteoarthritis (OA) progression through persistently producing pro‐inflammatory factors. Mesenchymal stem cells‐derived small extracellular vesicles (MSC‐sEVs) have shown anti‐inflammatory effects in OA models, while persistent existence of senescent chondrocytes still promotes cartilage destruction. Therefore, improving the targeted elimination ability on required to facilitate translation MSC‐sEVs treatment. In this study, versatile engineered are developed targetedly clear and maintain metabolic homeostasis. Specifically, loaded with siRNA mouse double minute 2 homologue (siMDM2) modified cartilage‐targeting peptide WYRGRL‐PEG 2K ‐DSPE (WPD), named WPD‐sEVs siMDM2 . The results demonstrate modification improves cellular uptake chondrocytes, thus antiaging effects. Importantly, multifunctional enhances penetration extends joint retention time MSC‐sEVs. both post‐traumatic mice naturally aged mice, more effectively eliminates maintained matrix By using P53 phosphorylation inhibitor, essential role MDM2‐P53 pathway function verified. ex vivo cultured human explants, it confirmed that alleviates phenotype. Altogether, findings suggest promising translational potential for

Язык: Английский

Процитировано

1

Mesenchymal stromal cells-derived extracellular vesicles in cartilage regeneration: potential and limitations DOI Creative Commons
María Piñeiro-Ramil,

Iván Gómez-Seoane,

Ana Isabel Rodríguez-Cendal

и другие.

Stem Cell Research & Therapy, Год журнала: 2025, Номер 16(1)

Опубликована: Янв. 23, 2025

Articular cartilage injuries can lead to pain, stiffness, and reduced mobility, may eventually progress osteoarthritis (OA). Despite substantial research efforts, effective therapies capable of regenerating are still lacking. Mesenchymal stromal cells (MSCs) known for their differentiation immunomodulatory capabilities, yet challenges such as limited survival post-injection inconsistent therapeutic outcomes hinder clinical application. Recent evidence suggests that the beneficial effects MSCs largely mediated by secreted small extracellular vesicles (sEVs), which have been shown promote tissue repair reduce inflammation. MSC-derived sEVs promise in mitigating degradation chondrocyte apoptosis, positioning them a promising alternative MSC-based OA treatment. This review explores potential limitations regeneration. systematic was conducted following PRISMA guidelines, with comprehensive search Web Science Scopus databases studies published between 2019 2024. A total 223 records were identified, 132 articles assessed eligibility based on general selection criteria. After full-text screening, 60 initially selected, comprising 58 vitro 40 vivo studies. Following further exclusion specific criteria, 33 28 from 47 scientific papers included final qualitative synthesis. Most indicate enhance proliferation, improve matrix composition, matrix-degrading enzymes inflammation, thereby delaying progression. growing body supports use tool preventing progression, most reporting structure function. However, remain optimizing standardizing isolation, dosage, delivery methods Further is necessary elucidate mechanisms underlying sEVs-mediated regeneration facilitate translation into therapies.

Язык: Английский

Процитировано

1

Pyroptosis: candidate key targets for mesenchymal stem cell-derived exosomes for the treatment of bone-related diseases DOI Creative Commons
Hong Li, Peng Zhang, Minghui Lin

и другие.

Stem Cell Research & Therapy, Год журнала: 2025, Номер 16(1)

Опубликована: Фев. 12, 2025

Bone-related diseases impact a large portion of the global population and, due to their high disability rates and limited treatment options, pose significant medical economic challenges. Mesenchymal stem cells (MSCs) can differentiate into multiple cell types offer strong regenerative potential, making them promising for treating various diseases. However, issues with immune response survival limit effectiveness transplantation. This has led increased interest in cell-free therapy, particularly use exosomes, which is most studied form this approach. Exosomes are extracellular vesicles that contain proteins, lipids, nucleic acids play key role communication material exchange. Pyroptosis, death involved innate immunity, also associated many Studies have shown MSC-derived exosomes therapeutic potential range conditions by regulating inflammation pyroptosis. study explored modulating pyroptosis improve bone-related

Язык: Английский

Процитировано

1

Novel 3D-printing bilayer GelMA-based hydrogel containing BP, β-TCP and exosomes for cartilage–bone integrated repair DOI
Ting Sun, Zhiqiang Feng, Wenpeng He

и другие.

Biofabrication, Год журнала: 2023, Номер 16(1), С. 015008 - 015008

Опубликована: Окт. 19, 2023

Abstract The integrated repair of cartilage and bone involves the migration differentiation cells, which has always been a difficult problem to be solved. We utilize natural biomaterial gelatin construct methacryloyl (GelMA), hydrogel scaffold with high cell affinity. GelMA is mixed different components print bi-layer porous modulus composition in upper lower layers through three-dimensional (3D) printing technology. adds black phosphorus (BP) human umbilical cord mesenchymal stem cells (hUMSCs) exosomes (exos) GelMA, relatively elastic conducive BMSCs into cartilage. In scaffold, addition BP hUMSCs exos, β -tricalcium phosphate ( -TCP), osteoconductive osteoinductive effects, added GelMA. -TCP significantly enhances osteogenic marrow cells(BMSCs). vitro experiments have confirmed that scaffolds can promote osteogenesis chondrogenic respectively. And rabbit cartilage–bone injury model, MRI micro-CT results show 3D printed composite effect close normal tissue.

Язык: Английский

Процитировано

17

Pyroptosis: A spoiler of peaceful coexistence between cells in degenerative bone and joint diseases DOI Creative Commons
Zhichao Li, Wenxiang Cheng,

Kuanhui Gao

и другие.

Journal of Advanced Research, Год журнала: 2024, Номер unknown

Опубликована: Июнь 1, 2024

As people age, degenerative bone and joint diseases (DBJDs) become more prevalent. When middle-aged elderly are diagnosed with one or disorders such as osteoporosis (OP), osteoarthritis (OA), intervertebral disc degeneration (IVDD), it often signals the onset of prolonged pain reduced functionality. Chronic inflammation has been identified underlying cause various diseases, including DBJDs. Recently, excessive activation pyroptosis, a form programed cell death (PCD) mediated by inflammasomes, emerged primary driver harmful chronic inflammation. Consequently, pyroptosis potential target for preventing treating This review explored physiological pathological roles pathway in development its relation to Meanwhile, elaborated molecular mechanisms within individual types marrow joints, well interplay among different context Furthermore, this presented latest compelling evidence supporting idea regulating DBJDs treatment, discussed potential, limitations, challenges therapeutic strategies involving regulation. In summary, an interesting identity unregulated was proposed review, which undertaken spoiler peaceful coexistence between cells environment. Over extended course DBJDs, perpetuated activity through crosstalk cascades types, thus exacerbating inflammatory environment throughout entire Correspondingly, regulation therapy promising option clinical treatment

Язык: Английский

Процитировано

7